SkyAI, Inc. SKYA
Medical/Dental Instruments · IPO 2022 · data as of November 13, 2026
SkyAI, Inc. (SKYA) is a healthcare company listed in the US with a market value of about $118M. In the twelve months to September 30, 2026 it had revenue of $192780 and net income of -$207M, a net margin of -107506.6%.
Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is value (2/5); the weakest is track record (0/5).
Key numbers: a P/E of 7.7, a 5-year average ROIC of -93%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 100% below the current price.
About SkyAI
SkyAI is listed in the US and classified in medical/dental instruments, IPO year 2022. It was profitable in 0 of the last 5 years in our data. Its share count rose by 2061437% over three years (dilution for shareholders). It spends 97% of revenue on research and development.
Score: 1.0 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 5 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $192780 | $204120 | — | — | — | — |
| Net income | -$207M | -$283M | -$9M | -$10M | -$5M | -$5M |
| Free cash flow | — | — | -$5M | -$9M | -$7M | -$5M |
| EPS (diluted) | $0.30 | $-11.16 | $-2219.92 | $-4982.27 | $-3761.45 | $-6335.08 |
| Net margin | -107506.6% | -138400.0% | — | — | — | — |
| ROIC | — | -79.7% | -96.1% | -127.2% | -71.6% | -92.6% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
What is SkyAI’s P/E ratio?
About 7.7, based on the last twelve months of diluted earnings per share.
Is SkyAI stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 100% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does SkyAI pay a dividend?
Not currently.
Is SkyAI a good stock to buy?
We do not give buy or sell advice. SkyAI scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.